Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:NLNK

NewLink Genetics (NLNK) Stock Price, News & Analysis

NewLink Genetics logo

About NewLink Genetics Stock (NASDAQ:NLNK)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$0.89
$14.10
52-Week Range
N/A
Volume
N/A
Average Volume
547,540 shs
Market Capitalization
$162.00 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive NLNK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NewLink Genetics and its competitors with MarketBeat's FREE daily newsletter.

NLNK Stock News Headlines

Reproduction DNA and Genetics
What Wall Street expects from NewLink Genetics's earnings
BRICS is accumulating all the gold they can get…
Five powerful nations are working to unseat the U.S. dollar — and their weapon of choice is gold. Led by the BRICS alliance, this shift is already underway… and it could trigger a historic surge in gold prices. A former gold cycle expert is now revealing what he believes could be the biggest metals move in decades — and how everyday investors can still get positioned in time.
Best DNA Test for 2024
Newlink Technology Inc.
Newlink Technology Inc (9600)
See More Headlines

NLNK Stock Analysis - Frequently Asked Questions

NewLink Genetics Corp (NASDAQ:NLNK) released its quarterly earnings data on Wednesday, November, 6th. The biotechnology company reported ($0.27) earnings per share for the quarter, hitting the consensus estimate of ($0.27). The biotechnology company had revenue of $0.25 million for the quarter. NewLink Genetics had a negative net margin of 4,592.84% and a negative trailing twelve-month return on equity of 41.50%.

Based on aggregate information from My MarketBeat watchlists, some other companies that NewLink Genetics investors own include Bristol Myers Squibb (BMY), Inovio Pharmaceuticals (INO), Arbutus Biopharma (ABUS), OPKO Health (OPK), Gilead Sciences (GILD), CSLM Acquisition (SPWR) and Sarepta Therapeutics (SRPT).

Company Calendar

Last Earnings
11/06/2019
Today
7/09/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
Biotechnology
Current Symbol
NASDAQ:NLNK
CIK
1126234
Fax
N/A
Employees
55
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$42.99 million
Net Margins
-4,592.84%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$940 thousand
Price / Cash Flow
N/A
Book Value
$2.11 per share
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$162.00 million
Optionable
Not Optionable
Beta
1.17
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (NASDAQ:NLNK) was last updated on 7/9/2025 by MarketBeat.com Staff
From Our Partners